文献速递乳腺MR

动态对比增强MRI结合条件生成对抗网络评估乳腺癌化疗反应

Dynamic Contrast-enhanced MRI for Evaluating Breast Cancer Chemotherapy Response Using Conditional Generative Adversarial Networks.
PubMed 文献 · Radiol Imaging Cancer · 2026-01-01

本研究开发并评估图像到图像条件生成对抗网络(cGAN),将乳腺癌动态对比增强MRI数据转换为血管药代动力学渗透性图。回顾性分析10例女性患者20次DCE MRI扫描共2400个层面,cGAN计算时间较扩展Tofts模型(ETM)缩短1000倍以上,生成的Ktrans图与ETM参考标准高度一致(R²≥0.98)。病理完全缓解患者首周期新辅助化疗后cGAN Ktrans降低60%(P=0.01),与ETM的59%(P=0.02)接近;非病理完全缓解患者仅降低17%(P=0.13),与ETM的15%(P=0.19)一致。Ktrans变化百分比可有效区分有无病理完全缓解(两种模型C统计量均为1.0)。

要点

  • cGAN将DCE MRI转换为Ktrans图的计算时间较ETM缩短1000倍以上,且与ETM空间一致性高(R²≥0.98)。
  • 病理完全缓解患者首周期化疗后cGAN Ktrans降低60%(P=0.01),非病理完全缓解患者仅降低17%(P=0.13)。
  • Ktrans变化百分比区分有无病理完全缓解的C统计量为1.0(cGAN与ETM模型均如此)。

核心结论

  • DCE到药代动力学的cGAN有望标准化药代动力学分析并降低DCE MRI计算复杂度,且可能用于早期预测乳腺癌新辅助化疗反应。

研究设计与样本

  • 回顾性研究,使用癌症影像档案库(The Cancer Imaging Archive)1996年4月至1998年1月采集的乳腺癌DCE MR图像,纳入10例女性患者(平均年龄45岁±12[SD])共20次DCE MRI扫描(2400个层面),以扩展Tofts模型(ETM)Ktrans图为参考标准,训练cGAN学习DCE MR数据与ETM Ktrans图之间的关系。

诊断标准与关键数值

  • cGAN Ktrans图与ETM的空间一致性高、结构相似度高,归一化均方根误差≤0.32,归一化平均绝对误差≤0.16,R²≥0.98;病理完全缓解患者首周期新辅助化疗后cGAN Ktrans降低60%(P=0.01)、ETM Ktrans降低59%(P=0.02);非病理完全缓解患者cGAN Ktrans降低17%(P=0.13)、ETM降低15%(P=0.19);Ktrans变化百分比区分有无病理完全缓解的C统计量为1.0(两种模型均如此)。

临床应用与阅片要点

  • 作者认为该DCE到药代动力学的cGAN有望用于标准化药代动力学分析并降低DCE MRI计算复杂度,且可能用于早期预测乳腺癌新辅助化疗反应。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Purpose To develop and evaluate an image-to-image conditional generative adversarial network (cGAN) for translating dynamic contrast-enhanced (DCE) MRI data to vascular pharmacokinetic permeability maps. Materials and Methods Retrospective breast cancer DCE MR images from The Cancer Imaging Archive acquired between April 1996 and January 1998 were used to assess the developed cGAN. The extended Tofts model (ETM) was applied to establish reference standard volume transfer constant (Ktrans) maps. The cGAN was trained to learn relationships between DCE MR data and ETM Ktrans maps. Linear regression was applied to determine agreement between the ETM and cGAN. Logistic regression and paired t tests were used to assess predictive capabilities of pathologic response. Results Twenty DCE MRI scans (n = 2400 sections) from 10 female patients (mean age, 45 years ± 12 [SD]) were analyzed. Computation time was reduced over 1000-fold using the cGAN compared with the ETM. The cGAN Ktrans maps exhibited excellent spatial agreement and high structural similarity to the ETM, with low errors (normalized root mean squared error ≤0.32; normalized mean absolute error ≤0.16) and a strong correlation (R2 ≥ 0.98). Patients with pathologic complete response demonstrated a 60% reduction in cGAN Ktrans (P = .01) after the first cycle of neoadjuvant chemotherapy, closely matching ETM Ktrans (59%, P = .02). In contrast, patients without pathologic complete response showed a modest reduction in cGAN Ktrans (17%, P = .13), still in good agreement with the ETM (15%, P = .19). Percentage of Ktrans change effectively distinguished patients with or without pathologic complete response (C statistic = 1.0) for both models. Conclusion The DCE to pharmacokinetic cGAN offers promise for standardizing pharmacokinetic analysis and reducing computational complexity at DCE MRI. Moreover, this approach demonstrated potential for early prediction of breast cancer responses to neoadjuvant chemotherapy. Keywords: Dynamic Contrast-enhanced MRI, Vascular Permeability, Image-to-Image Conditional Generative Adversarial Network, Breast Cancer, Neoadjuvant Chemotherapy © RSNA, 2025.

来源:Radiol Imaging Cancer,查看原文。版权归原作者所有。

引用

  1. Arledge CA, Zhao AH, Topaloglu U, et al. Dynamic Contrast-enhanced MRI for Evaluating Breast Cancer Chemotherapy Response Using Conditional Generative Adversarial Networks. Radiol Imaging Cancer. 2026. PMID: 41347917. doi:10.1148/rycan.250110

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。